VYOME HOLDINGS, INC. Payments of Stock Issuance Costs
VYOME HOLDINGS, INC. (HIND) reported Payments of Stock Issuance Costs of $100.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Cash Flow › Financing Activities
us-gaap:PaymentsOfStockIssuanceCosts · last filed 2026-08-12
- VYOME HOLDINGS, INC. payments of stock issuance costs for the quarter ending 2026-06-30 was $0.00.
- VYOME HOLDINGS, INC. payments of stock issuance costs for the quarter ending 2026-03-31 was $100.00K.
- VYOME HOLDINGS, INC. payments of stock issuance costs for fiscal 2025 was $100.00K.
| Period end | Payments of Stock Issuance Costs 3 month | Payments of Stock Issuance Costs 6 month | Payments of Stock Issuance Costs 9 month | Payments of Stock Issuance Costs 12 month |
|---|---|---|---|---|
| 2026-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-12 | $100.00K 10-Q · filed 2026-08-12 | ||
| 2026-03-31 | $100.00K 10-Q · filed 2026-05-12 | |||
| 2025-12-31 | $100.00K 10-K · filed 2026-03-18 | |||
| 2023-09-30 | $338.00K 10-Q · filed 2024-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |